FTC opposes Boehringer's attempt to delay production of documents
MLex Summary: The US Federal Trade Commission has filed an opposition to Boehringer Ingelheim Pharmaceuticals’ motion to stay a mandate by the US Court of Appeals for the District of Columbia...To view the full article, register now.
Already a subscriber? Click here to view full article